- conflicts or gaps
- [[{"field": "headquarters_location", "conflict": {"value": "YC and 2022 BusinessWire list San Francisco, CA; 2025 company site lists Brisbane, CA HQ address and cites Brisbane + Boston presence", "source_urls": ["https://www.ycombinator.com/companies/64x-bio", "https://www.businesswire.com/news/home/20220119005386/en/64x-Bio-Raises-55-Million-Series-A-Financing-to-Advance-Cell-Line-Engineering-Platform-for-Gene-Therapy-Manufacturing", "https://64xbio.com/company"]}}, {"field": "founded_year", "conflict": {"value": "YC lists founded 2017; LinkedIn/CB Insights aggregators list 2018", "source_urls": ["https://www.ycombinator.com/companies/64x-bio", "https://www.linkedin.com/company/64xbio"]}}, {"field": "employee_count", "conflict": {"value": "YC team_size=25 vs LinkedIn ~15 employees", "source_urls": ["https://www.ycombinator.com/companies/64x-bio", "https://www.linkedin.com/company/64xbio"]}}, {"field": "founders_list", "conflict": {"value": "George Church listed co-founder on YC/company/BusinessWire but omitted from Crunchbase founders list in public profile", "source_urls": ["https://www.ycombinator.com/companies/64x-bio", "https://www.crunchbase.com/organization/64-x-mountain-view-california"]}}, {"field": "david_thompson_role", "conflict": {"value": "Listed co-founder on YC/company site; 2020 BioSpace stealth article lists David Thompson as key advisor, not co-founder", "source_urls": ["https://www.ycombinator.com/companies/64x-bio", "https://64xbio.com/company", "https://www.biospace.com/64x-bio-emerges-from-stealth-to-drive-an-evolution-in-cell-and-gene-therapy-manufacturing"]}}, {"field": "total_funding", "gap": {"value": "Primary sources confirm $4.5M seed (2020) and $55M Series A (2022) only; aggregators cite $59.6M–$60.5M totals implying additional undisclosed YC/seed rounds without primary dollar amounts", "source_urls": ["https://www.biospace.com/64x-bio-emerges-from-stealth-to-drive-an-evolution-in-cell-and-gene-therapy-manufacturing", "https://www.businesswire.com/news/home/20220119005386/en/64x-Bio-Raises-55-Million-Series-A-Financing-to-Advance-Cell-Line-Engineering-Platform-for-Gene-Therapy-Manufacturing", "https://www.linkedin.com/company/64xbio"]}}, {"field": "valuation", "gap": {"value": "No public post-money valuation found in reviewed primary sources", "source_urls": ["https://www.businesswire.com/news/home/20220119005386/en/64x-Bio-Raises-55-Million-Series-A-Financing-to-Advance-Cell-Line-Engineering-Platform-for-Gene-Therapy-Manufacturing"]}}, {"field": "aav_apex_partners", "gap": {"value": "Five biopharma/CDMO collaborators cited at launch but not named publicly", "source_urls": ["https://www.businesswire.com/news/home/20250616379943/en/64x-Bio-Launches-AAV-Apex-Suite-to-Power-the-Next-Generation-of-Gene-Therapy-Manufacturing"]}}, {"field": "revenue", "gap": {"value": "No audited revenue disclosed in primary sources; LinkedIn aggregate cites ~$5M annual revenue without verification", "source_urls": ["https://www.linkedin.com/company/64xbio", "https://64xbio.com/company"]}}]]
- source urls
- ["https://64xbio.com/company", "https://64xbio.com/platform", "https://64xbio.com/products", "https://www.biospace.com/64x-bio-emerges-from-stealth-to-drive-an-evolution-in-cell-and-gene-therapy-manufacturing", "https://www.businesswire.com/news/home/20220119005386/en/64x-Bio-Raises-55-Million-Series-A-Financing-to-Advance-Cell-Line-Engineering-Platform-for-Gene-Therapy-Manufacturing", "https://www.businesswire.com/news/home/20250616379943/en/64x-Bio-Launches-AAV-Apex-Suite-to-Power-the-Next-Generation-of-Gene-Therapy-Manufacturing", "https://www.crunchbase.com/organization/64-x-mountain-view-california", "https://www.linkedin.com/company/64xbio", "https://www.synbiobeta.com/read/64x-bio-unveils-aav-apex-suite-to-address-gene-therapy-manufacturing-bottlenecks", "https://www.ycombinator.com/companies/64x-bio", "https://yc-oss.github.io/api/batches/summer-2018/64x-bio.json"]